The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome

Clinica Chimica Acta

Volumn 413, Issue 9-10, 2012, Pages 911-913

  Hoxha, A ^a   Ruffatti, A ^a   Pittoni, M ^b   Bontadi, A ^a   Tonello, M ^a   Salvan, E ^a   Plebani, M ^b   Punzi, L ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Anti prothrombin antibodies; Antiphospholipid antibodies; Antiphospholipid syndrome

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; PROTHROMBIN; PROTHROMBIN ANTIBODY;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; THROMBOSIS;

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PREGNANCY; PROTHROMBIN; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84858618879     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.02.004     Document Type: Article

References (19)

1. Miyakis S., Lockshin M.D., Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306.
2. Fleck R.A., Rapaport S.I., Rao L.V. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988, 72:512-519.
3. Oosting J.D., Derksen R.H., Bobbink I.W., et al. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenetic mechanism?. Blood 1993, 81:2618-2625.
4. de Groot P.G., Horbach D.A., Simmelink M.J., van Oort E., Derksen R.H. Anti-prothrombin antibodies and their relation with thrombosis and lupus anticoagulant. Lupus 1998, 7:32-36.
5. Oku K., Atsumi T., Amengual O., Koike T. Antiprothrombin antibody testing: detection and clinical utility. Semin Thromb Hemost 2008, 34:335-339.
6. Amengual O., Atsumi T., Koike T. Specifities, properties and clinical significance of antiprothrombin antibodies. Arthritis Rheum 2003, 48:886-895.
7. Sabatini L., Torricelli M., Scaccia V., et al. Increased plasma concentrations of antiprothrombin antibodies in women with recurrent spontaneous abortions. Clin Chem 2007, 53:228-232.
8. Sailer T., Vormittag R., Zoghlami C., et al. The clinical significance of anti-prothrombin antibodies for risk assessment of thromboembolism in patients with lupus anticoagulant. Thromb Res 2007, 120:295-302.
9. Nojima J., Kuratsune H., Suehisa E., et al. Association between the prevalence of antibodies to β2-glycoprotein I, prothrombin, protein C, protein S and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clin Chem 2001, 47:1008-1015.
10. Ishikura K., Wada H., Kamikura Y., et al. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis. Am J Hematol 2004, 76:338-342.
11. Bertolaccini M.L., Atsumi T., Koike T., Hughes G.R., Khamashta M.A. Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus. Thromb Haemost 2005, 93:289-297.
12. von Landenberg P., Matthias T., Zaech J.M. Antiprothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome. Am J Reprod Immunol 2003, 49:51-56.
13. Pengo V., Denas G., Bison E., et al. Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA). Thromb Res 2010, 126:150-153.
14. Galli M. Antiphospholipid antibodies and thrombosis: do test patterns identify the patients' risk?. Thromb Res 2004, 114:597-601.
15. Tincani A., Allegri F., Balestrieri G., et al. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res 2004, 114:553-558.
16. 2-Glycoprotein I antibodies. Standardization Group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost 2004, 2:1860-1862.
17. Ruffatti A., Olivieri S., Tonello M., et al. Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification. J Thromb Haemost 2008, 6:1693-1696.
18. Cavazzana A., Ruffatti A., Tonello M., et al. An analysis of experimental conditions influencing the anti-beta2-glycoprotein I ELISA assay results. Ann N Y Acad Sci 2007, 1109:484-492.
19. Pengo V., Tripodi A., Reber G., et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009, 7:1737-1740.